1355052-60-6

Basic information

• Product Name: 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-5-(trifluoromethyl)pyridine
• Synonyms: 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-5-(trifluoromethyl)pyridine
• CAS NO: 1355052-60-6
• Molecular Weight: 365.16
• Mol File: 1355052-60-6.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-5-(trifluoromethyl)pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-5-(trifluoromethyl)pyridine(1355052-60-6)
• EPA Substance Registry System: 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-5-(trifluoromethyl)pyridine(1355052-60-6)

Safety Data

• Hazardous Substances Data: 1355052-60-6(Hazardous Substances Data)

Upstream product

• 100366-75-4 2‐iodo‐5‐(trifluoromethyl)pyridine 
• 137736-63-1 2-(4-bromophenoxy)-5-(trifluoromethyl)pyridine 
• 73183-34-3 bis(pinacol)diborane 
• 106-41-2 4-bromo-phenol 
• 69045-82-5 2-fluoro-5-(trifluoromethyl)pyridine 
• 269409-70-3 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol 

Downstream Products

• 1355052-61-7 C₁₈H₁₁F₃N₂O₃ 
• 1599467-89-6 6-chloro-4-ethoxy-7-methoxy-2-methyl-3-(4-((5-(trifluoromethyl)pyridin-2-yl)oxy)phenyl)quinoline 
• 1623733-94-7 (S)-4-((2-oxopyrrolidin-3-yl)amino)-6-(4-((5-(trifluoromethyl)pyridin-2-yl)oxy)phenyl)-1,3,5-triazine-2-carbonitrile 
• 1623733-97-0 (S)-4-((2-oxopyrrolidin-3-yl)amino)-6-(4-((5-(trifluoromethyl)pyridin-2-yl)oxy)phenyl)-1,3,5-triazine-2-carboxamide 
• 1355052-23-1 C₂₉H₂₂F₃N₅O₄S 
• 1355052-22-0 (S)-N-(1-amino-1-oxopropan-2-yl)-6-(4-((5-(trifluoromethyl)pyridin-2-yl)oxy)phenyl)picolinamide 
• 1355052-59-3 C₂₂H₁₈F₃N₃O₄ 

Relevant articles and documents

PYRIMIDINES AND USE THEREOF

The present disclosure provides pyrimidines of Formula I: and pharmaceutically acceptable salts and solvates thereof, wherein A1, X, A2, G, Y, n, R2a, R2b, and R3 are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula I and the pharmaceutically acceptable salts and solvates thereof to treat a disorder responsive to the blockade of one or more sodium channels. In one embodiment, compounds of the present disclosure are useful for treating pain.

TRIAZINE CARBOXAMIDES AS SODIUM CHANNEL BLOCKERS

The present disclosure provides substituted triazine carboxamides of Formula I: and the pharmaceutically acceptable salts and solvates thereof, wherein A1, X, A2, E, and Z are defined as set forth in the specification. The present di

PYRIDINE COMPOUNDS AS SODIUM CHANNEL BLOCKERS

The invention relates to substituted pyridine compounds of Formula I: (I) or a pharmaceutically acceptable salt, prodrug, or solvate thereof, wherein A1, X, A2, R1a, R1b, R1c, G, and z are defined as